RSS Newsfeed  Your shopping cart.
home
SEARCH

Search in

Keyword

GMP News
30 May 2007
 

OECD Analyses Economic Effects of Counterfeiting and Piracy of Pharmaceuticals

 
In response to rising concerns by government and the business community, the Organisation for Economic Co-operation and Development (OECD) has launched a project to assess the effects of counterfeiting and piracy on economies. The objective of the project is to improve factual understanding and awareness of the effects that counterfeiting and piracy of intellectual property rights have on governments, business and consumers. This project will focus on counterfeit and pirated products from an intellectual property perspective (i.e. tangible products that infringe trademarks, copyrights, patents and design rights.

Within this project, a number of sectoral case studies will be conducted, illustrating the various forms of counterfeiting and piracy, and the effects on producers, consumers and governments. The pharmaceutical sector has been identified, since counterfeiting of medicines has significant safety, health, social and economic implications. A sector report on the counterfeiting and piracy of pharmaceuticals will be part of the OECD project. A separate and second report focusing solely on the counterfeiting of pharmaceuticals, from a broader, public-health perspective, is also being produced. The report will examine the diverse definitions of counterfeit pharmaceuticals, the nature and scope of counterfeiting activities, and the procedures used. It will assess the trends and magnitude, evaluate the impacts on patients/consumers (especially public health implications) on the private sector and on governments. It will analyse measures employed for combating counterfeiting of pharmaceuticals. Anticipated publication in 2007.

Source: OECD Health Update, Issue No.3, May 2007
  

Hear representatives from MHRA and WHO speak at the ECA Conference

Also specialists from the pharmaceutical industry and service providers will share their expert knowledge about all relevant aspects regarding the current expectations and the actual development in Good Distribution Practice, Cold Chain Management and Anti-Counterfeiting Strategies.

 
Author:
Wolfgang Schmitt
On behalf of the European Compliance Academy (ECA)
 

+++Update:

The information in this article may be outdated. In order to find updated information on this subject (e.g. new developments, training courses) please enter a keyword into the search engine at the top of this page.

You may also use our GMP Guideline Database to search for the current Guidelines.

If you want to receive the latest information about major GMP developments on a regular basis you may want to register for our free GMP Newsletter.
 

 

 GMP Conferences by Topics
 Quality Assurance
 GMP in Biotechnology
 Microbiology
 Regulatory Affairs
 GMP in Pharmaceutical Development
 Quality Control
 Storage, Distribution, Transportation
 Sterile / Aseptic Manufacturing
 Computer Validation
 Technical Operations
 GMP for APIs and Excipients
 Validation
 Medical Devices